EPAM Stock Cash Flow Statements

EPAM Systems Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

EPAM Systems Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31

cash flows from operating activities:
net income	88,026,000	73,482,000	103,299,000	136,346,000	98,645,000	116,243,000	97,554,000	97,204,000	120,033,000	102,292,000	155,039,000	156,054,000	18,604,000	89,719,000	142,279,000	115,656,000	114,671,000	109,046,000	85,539,000	89,432,000	66,624,000	85,565,000	74,524,000	67,002,000	58,777,000	60,754,000	59,965,000	65,618,000	50,255,000	64,418,000	-30,874,000	42,634,000	37,359,000	23,641,000	24,763,000	26,174,000	24,430,000	23,899,000	27,638,000	22,873,000	19,231,000	14,714,000	18,423,000	19,040,000	14,814,000	17,364,000	18,759,000	16,437,000	14,118,000	12,680,000	14,999,000	14,065,000	13,321,000	12,099,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization expense	31,274,000	31,437,000	26,556,000	19,736,000	21,121,000	22,146,000	23,158,000	23,092,000	22,768,000	22,782,000	23,146,000	21,876,000	22,991,000	24,259,000	23,597,000	21,543,000	20,454,000	17,807,000	16,779,000	15,929,000	15,226,000	14,940,000	12,962,000	11,127,000	11,028,000	10,200,000	10,183,000	9,319,000
operating lease right-of-use assets amortization expense	10,652,000	9,929,000	9,494,000	9,278,000	9,339,000	9,434,000	10,060,000	10,214,000	10,585,000	10,043,000	10,441,000	11,299,000	11,250,000	14,787,000	15,057,000	15,197,000	15,820,000	15,676,000	15,902,000	16,633,000	17,018,000	16,816,000	15,656,000	14,471,000	13,545,000	12,187,000
bad debt expense/																														199,000
deferred taxes	-8,476,000	2,386,000	-39,307,000	-12,877,000	-13,877,000	1,866,000	-25,434,000	-16,363,000	3,780,000	823,000	12,687,000	-25,446,000	-18,575,000	-10,830,000	-39,952,000	-8,124,000	-5,516,000	6,692,000	-15,448,000	-7,517,000	-5,317,000	8,288,000	-4,659,000	-1,912,000	-2,039,000	846,000	-11,628,000	-8,791,000	-4,291,000	-23,290,000				2,595,000	-3,293,000	-80,000	551,000	-482,000	-15,863,000	163,000	277,000	95,000	-3,545,000	80,000	98,000	97,000	-694,000	205,000	262,000	268,000	-3,559,000	-413,000	62,000	-23,000
stock-based compensation expense	38,558,000	48,456,000	44,698,000	42,124,000	35,684,000	44,791,000	38,194,000	37,847,000	33,110,000	38,579,000	31,617,000	33,287,000	27,893,000	7,112,000	34,017,000	29,187,000	23,898,000	24,553,000	20,444,000	23,474,000	19,439,000	11,881,000	19,012,000	15,471,000	15,697,000	21,856,000	12,452,000	15,330,000	14,810,000	16,596,000	12,487,000	11,217,000	12,927,000	15,776,000	11,724,000	13,826,000	12,730,000	10,964,000	12,483,000	11,963,000	12,253,000	9,134,000	8,096,000	7,425,000	5,891,000	3,208,000	3,359,000
other	1,867,000	3,729,000	-988,000	-5,751,000	1,982,000	10,484,000	-1,705,000	1,553,000	2,821,000	-3,268,000	-31,108,000	-11,519,000	72,072,000	3,361,000	8,825,000	9,502,000	-264,000	-4,926,000	3,571,000	-1,233,000	-1,435,000	5,893,000	-2,758,000	3,584,000	3,418,000	520,000	1,722,000	-1,335,000	-117,000	-1,982,000	-514,000	-1,946,000	-2,201,000	651,000	4,394,000	831,000	953,000	50,000	1,525,000	273,000	-2,879,000	4,964,000	-1,872,000	271,000	2,042,000	294,000	59,000	1,000	553,000	586,000	-36,000	110,000	517,000	-657,000
changes in assets and liabilities:
trade receivables and contract assets	-39,672,000	-76,680,000	38,379,000	40,210,000	-26,840,000	-36,161,000	26,211,000	-5,839,000	15,557,000	-3,573,000	3,963,000	-13,532,000	-38,360,000	-144,783,000	21,026,000	-64,672,000	-78,643,000	-89,395,000	758,000	15,319,000	39,581,000	-51,423,000
prepaid and other assets	13,373,000	-9,163,000	-24,792,000	-48,508,000	556,000	-4,215,000	-4,799,000	4,228,000	9,085,000	-105,000	-4,353,000	-4,437,000	6,165,000	-9,515,000	-7,414,000	-973,000	786,000	-8,581,000	2,722,000	3,045,000	10,962,000	-9,746,000
accounts payable	-745,000	502,000	-24,473,000	-2,257,000	3,129,000	-5,483,000	-683,000	-947,000	290,000	1,494,000	-11,703,000	8,044,000	5,358,000	-4,633,000	4,065,000	-2,520,000	-782,000	-3,166,000	592,000	1,203,000	3,040,000	-2,407,000	159,000	225,000	419,000	-2,488,000	-2,346,000	566,000	-1,512,000	2,520,000	-664,000	1,367,000	441,000	77,000	-1,270,000	1,550,000	-210,000	671,000	-10,909,000	385,000	-1,926,000	9,669,000	-2,339,000	-6,163,000	-2,664,000	8,563,000	-5,375,000	-155,000	-379,000	3,009,000	3,505,000	-2,447,000	-1,045,000	1,394,000
accrued expenses and other liabilities	-33,458,000	-27,248,000	-6,589,000	61,965,000	-42,954,000	-1,749,000	10,960,000	32,928,000	-70,035,000	-58,463,000	33,125,000	55,053,000	12,776,000	-74,929,000	68,835,000	93,594,000	9,058,000	-15,830,000	29,346,000	36,622,000	-11,272,000	5,437,000	30,217,000	31,328,000	16,659,000	-51,079,000	32,304,000	25,486,000	15,609,000	-31,470,000	18,557,000	22,058,000	15,151,000	-18,484,000	13,016,000	5,040,000	2,116,000	-34,098,000	15,719,000	15,004,000	6,214,000	-10,374,000	5,146,000	8,518,000	5,736,000	-7,908,000	11,323,000				5,493,000	3,198,000
operating lease liabilities	-10,598,000	-10,975,000	-9,761,000	-10,224,000	-9,437,000	-9,943,000	-13,783,000	-11,059,000	-12,579,000	-10,672,000	-10,273,000	-12,380,000	-14,844,000	-14,171,000	-15,654,000	-15,882,000	-16,211,000	-16,065,000	-17,430,000	-16,166,000	-15,211,000	-15,646,000	-14,189,000	-13,525,000	-12,530,000	-13,175,000
income taxes payable	-37,990,000	-21,475,000	15,052,000	12,296,000	-19,414,000	-16,100,000	4,997,000	15,362,000	-48,783,000	-4,964,000	-15,860,000	44,263,000	-22,133,000	-2,670,000	30,018,000	13,797,000	-14,338,000	-25,909,000	17,198,000	-797,000	7,046,000	-9,062,000
net cash from operating activities	53,198,000	24,162,000	130,259,000	241,962,000	57,027,000	129,920,000	171,369,000	214,879,000			186,069,000	252,368,000			284,614,000	206,050,000	68,836,000	12,827,000	159,432,000	175,564,000			124,587,000	119,039,000			123,130,000	102,299,000	59,459,000	7,330,000	71,384,000	64,884,000	27,868,000	31,228,000	53,651,000	61,812,000	38,493,000	10,861,000	11,839,000	55,520,000	2,163,000	6,871,000	48,705,000				46,430,000			-11,738,000	35,759,000	11,111,000
capex	-9,831,000	-9,329,000	-15,727,000	-4,966,000	-4,704,000	-6,749,000	-9,995,000	-3,624,000			-21,495,000	-18,708,000			-56,617,000	-21,111,000	-22,587,000	-11,186,000	-18,482,000	-9,787,000			-47,013,000	-27,270,000			-10,109,000	-8,162,000	-8,592,000	-10,711,000	-12,925,000	-5,440,000	-5,716,000	-5,725,000	-9,336,000	-6,392,000	-7,404,000	-6,185,000	-3,739,000	-4,191,000	-3,469,000	-1,873,000	-3,752,000				-2,432,000			-2,887,000	-3,059,000	-3,907,000
free cash flows	43,367,000	14,833,000	114,532,000	236,996,000	52,323,000	123,171,000	161,374,000	211,255,000			164,574,000	233,660,000			227,997,000	184,939,000	46,249,000	1,641,000	140,950,000	165,777,000			77,574,000	91,769,000			113,021,000	94,137,000	50,867,000	-3,381,000	58,459,000	59,444,000	22,152,000	25,503,000	44,315,000	55,420,000	31,089,000	4,676,000	8,100,000	51,329,000	-1,306,000	4,998,000	44,953,000				43,998,000			-14,625,000	32,700,000	7,204,000
cash flows from investing activities:
purchases of property and equipment	-9,831,000	-9,329,000	-15,727,000	-4,966,000	-4,704,000	-6,749,000	-9,995,000	-3,624,000	-6,883,000	-7,913,000	-21,495,000	-18,708,000	-18,152,000	-23,274,000	-56,617,000	-21,111,000	-22,587,000	-11,186,000	-18,482,000	-9,787,000	-11,449,000	-29,075,000	-47,013,000	-27,270,000	-11,601,000	-13,424,000	-10,109,000	-8,162,000	-8,592,000	-10,711,000	-12,925,000	-5,440,000	-5,716,000	-5,725,000	-9,336,000	-6,392,000	-7,404,000	-6,185,000	-3,739,000	-4,191,000	-3,469,000	-1,873,000	-3,752,000	-3,719,000	-2,288,000	-2,157,000	-2,432,000	-1,930,000	-6,111,000	-2,887,000	-3,059,000	-3,907,000	-3,086,000	-3,324,000
purchases of short-term investments	-47,000	-1,991,000	643,000	-659,000	4,000	-1,217,000	-304,000	0			0	0							-60,000,000	0
proceeds from short-term investments			20,000,000	40,000,000	1,199,000	310,000	0								0	0	0	60,000,000
acquisition of business, net of cash acquired	-6,671,000	3,325,000		-359,000	-12,567,000	-44,139,000						91,000	-2,414,000	-8,207,000		-39,712,000				-6,315,000	-2,234,000	-10,339,000								-50,264,000																						0
purchases of non-marketable securities	0	-360,000	-685,000	-18,000	-6,709,000	-200,000	-15,000	-1,375,000	0	-1,906,000	0				0	0	-1,500,000	-1,044,000	0	0
proceeds from non-marketable securities	0	2,913,000
other investing activities	-1,665,000	134,000	638,000	738,000	-69,000	1,005,000	437,000	-261,000	-45,000	-7,898,000	-9,530,000	-8,458,000	-7,959,000	-3,082,000	179,000	-279,000	-512,000	691,000	566,000	426,000	97,000	-71,000	-107,000	-452,000	-1,044,000	-5,136,000	772,000	-1,601,000	148,000	-18,000	-148,000	-1,114,000	-227,000	37,000
net cash from investing activities	-18,214,000	-5,308,000	-845,880,000	34,736,000	-22,846,000	-50,990,000	-20,697,000	-10,561,000	-17,793,000	-17,717,000	-31,139,000	-28,700,000			-210,432,000	-61,102,000			-17,907,000	-15,676,000	-74,086,000	-59,485,000	-57,787,000	-40,137,000	-28,885,000	-18,560,000	-34,290,000	-9,519,000	-8,150,000	-60,164,000	-12,159,000	-6,440,000							-52,319,000	-33,696,000	-5,597,000	-33,882,000	-14,521,000	-5,197,000	-21,535,000	-11,676,000	-2,945,000	-4,889,000	-7,512,000	-6,474,000	-28,264,000	-14,825,000	-12,819,000	-3,719,000
cash flows from financing activities:
proceeds from issuance of stock under the employee incentive programs	15,099,000	19,480,000		1,305,000	17,865,000	14,611,000	23,024,000	2,981,000	23,143,000	2,488,000	19,292,000	9,203,000
payments of withholding taxes related to net share settlements of restricted stock units	-22,045,000	-1,293,000	-2,725,000	-1,865,000	-27,810,000	-2,790,000	-900,000	-2,511,000	-22,538,000	-3,153,000	-4,455,000	-1,305,000	-16,920,000	-3,876,000	-7,490,000	-412,000	-30,392,000	-3,304,000	-3,919,000	-314,000	-14,881,000	-1,018,000	-982,000	-1,437,000	-11,876,000	-1,208,000		-372,000	-6,590,000	-106,000	-106,000	-386,000	-8,000	-2,694,000
repayment of debt	-404,000	-684,000	-368,000	-373,000	-535,000	-589,000	-362,000	-643,000	-553,000	-1,411,000	-4,000,000	-786,000	-3,920,000	-6,836,000									-2,000	-1,000	-2,000	-4,000	-9,000	-7,000	-12,000	-3,466,000	-14,000	-30,000	-25,029,000	-30,000	-8,033,000	-7,036,000	-29,000	-15,031,000
repurchase of common stock	-196,533,000	-159,998,000	-13,003,000	-49,955,000	-214,477,000	-120,593,000	-36,491,000	-78,486,000	-41,437,000	-8,510,000																																										-11,000	0	-50,000
payment of contingent consideration for previously acquired business	0	-4,746,000		0	-2,375,000	-2,375,000		0	-4,006,000	-4,678,000		-6,419,000	0	-207,000		250,000				0	0	-7,869,000
purchase of subsidiary shares from noncontrolling interest	0	-1,358,000					0	0
other financing activities	-172,000	-915,000	-1,106,000	-2,618,000	1,252,000	-345,000	-1,158,000	-2,518,000	-151,000	-226,000	-441,000	-904,000	-256,000	-1,865,000	-2,555,000	94,000	-123,000	260,000	7,000	-4,000	-15,000	-9,000	-5,000	-6,000	-4,000	-9,000	0	0			-19,000	-58,000
net cash from financing activities	-204,055,000	-149,514,000	1,260,000	-53,506,000	-226,080,000	-112,081,000	-22,356,000	-80,586,000	-47,513,000	-15,318,000	8,045,000	568,000				4,498,000							7,216,000	4,939,000	-1,973,000	10,181,000	2,150,000	9,260,000	7,575,000	4,016,000	9,530,000	6,084,000	26,250,000	7,882,000				9,789,000	28,313,000			1,490,000	988,000	1,785,000	4,440,000	3,134,000		4,104,000	4,564,000	4,039,000			-212,000	31,309,000
effect of exchange rate changes on cash, cash equivalents and restricted cash	37,050,000	18,770,000	-35,954,000	25,904,000	-6,887,000	-19,560,000	35,011,000	-22,728,000	3,026,000	14,070,000	31,009,000	-30,215,000	-254,000	-45,407,000	-5,341,000	-8,930,000	8,095,000	-11,856,000	19,467,000	1,889,000	10,010,000	-22,009,000	9,283,000	-8,001,000	1,700,000	548,000	-5,580,000	-1,015,000	-10,685,000	3,040,000
net decrease in cash, cash equivalents and restricted cash	-132,021,000	-111,890,000																				-20,285,000				-8,033,000
cash, cash equivalents and restricted cash, beginning of period	0	1,290,392,000	0	0	0	2,043,108,000	0	0	0	1,683,636,000	0	0	0	1,449,347,000	0	0	0	1,323,533,000	0	0	0	937,688,000	0	0	0	771,711,000	0	0	0	582,855,000
cash, cash equivalents and restricted cash, end of period	-132,021,000	1,178,502,000	-750,315,000	249,096,000	-198,786,000	1,990,397,000	163,327,000	101,004,000	26,772,000	1,752,005,000	193,984,000	194,021,000	-12,294,000	1,307,925,000	23,782,000	140,516,000	-89,245,000	1,374,294,000	161,310,000	167,342,000	77,478,000	917,403,000	83,299,000	75,840,000	14,871,000	763,678,000	85,410,000	101,025,000	48,199,000	537,077,000
bad debt recovery		-218,000																																																				-374,000
bad debt (recovery)/expense			-1,331,000	-674,000	-959,000	-1,438,000																				-133,000								-517,000
unrealized (gain)/loss on derivative instruments								0
impairment charges			22,000	298,000	52,000	45,000	5,331,000	29,000	571,000	88,000	2,407,000	210,000	601,000	20,401,000
loss on sale of business							0
acquisition of businesses, net of cash acquired																							-10,667,000	-12,415,000			-24,004,000	0			0	0			-1,001,000	-1,984,000			-49,254,000	-27,624,000	0	-30,000	-10,595,000	0	-24,079,000	-2,419,000
proceeds from sale of non-marketable securities
proceeds from issuance of stock under employee incentive programs
proceeds from debt							61,000	591,000	1,000	172,000	-2,351,000	887,000	1,296,000	1,931,000																	0	0			0	0	0	20,000,000
payment of contingent consideration for previously acquired businesses
net (decrease)/increase in cash, cash equivalents and restricted cash			-750,315,000	249,096,000	-198,786,000	-52,711,000								-141,422,000																-45,778,000
unrealized gain on derivative instruments
cash sold as part of sale of business, net of proceeds							0
bad debt expense							1,308,000	708,000	1,849,000	182,000	-494,000	1,140,000	3,073,000	8,675,000	-85,000	-255,000	-97,000	2,925,000	-541,000	-380,000	455,000	2,719,000	1,486,000	-34,000			-917,000	236,000			-28,000	-23,000			-151,000	-40,000	1,178,000	552,000	497,000	209,000	187,000	514,000	-129,000	177,000	401,000	368,000					197,000
unrealized (gain)/ loss on derivative instruments
payment of deferred consideration for asset acquisitions
net increase in cash, cash equivalents and restricted cash							163,327,000				193,984,000				23,782,000				161,310,000	167,342,000			83,299,000	75,840,000			85,410,000	101,025,000
net increase/(decrease) in cash, cash equivalents and restricted cash									26,772,000	68,369,000								50,761,000
adjustments to reconcile net income to net cash provided by/(used in) operating activities:
unrealized (gain)/loss on derivative										-7,904,000
net cash provided by/(used in) operating activities										87,334,000												63,255,000
purchase of noncontrolling interest											0	-108,000	0	-2,146,000
unrealized loss on derivative											-12,565,000	-11,544,000	-9,356,000	41,369,000
adjustments to reconcile net income to net cash (used in)/provided by operating activities:
net cash (used in)/provided by operating activities														-51,848,000												-202,000																												-4,745,000
net cash (used in)/provided by investing activities														-34,563,000																				-5,644,000
proceeds from stock option exercises														3,395,000	6,110,000	4,566,000	11,237,000	4,373,000	3,383,000	5,883,000	10,294,000	6,850,000	8,205,000	6,383,000	11,013,000	11,402,000	2,838,000	9,639,000	14,780,000	7,588,000		6,558,000	27,151,000	10,606,000
net cash (used in)/provided by financing activities														-9,604,000					318,000	5,565,000	-4,602,000	-2,046,000
net cash provided by/(used in) investing activities																		48,461,000																		-8,708,000
net cash provided by/(used in) financing activities																		1,329,000																		-3,345,000															4,180,000
payments for cost method investments																						-20,000,000
decrease in time deposits																													0	418,000
acquisition of businesses, contingent consideration																							0	0
accounts receivable																								3,829,000	-35,762,000	-8,820,000	-14,747,000	-1,207,000	-27,526,000	12,475,000	-34,349,000	-19,766,000	-29,265,000	24,635,000	-15,811,000	-9,335,000	-22,459,000	16,993,000	-44,119,000	9,634,000	-28,471,000	15,262,000	-12,284,000	-10,954,000	-12,080,000	4,908,000	-6,213,000	-4,526,000	-8,227,000	1,664,000	-6,581,000	720,000	-13,171,000	6,368,000
unbilled revenues																								-6,330,000	8,773,000	-39,523,000	25,647,000	-6,210,000	12,859,000	-48,193,000	19,797,000	1,593,000	-4,648,000	-39,485,000	19,144,000	14,010,000	20,182,000	-18,559,000	11,034,000	-13,175,000	-3,674,000	-32,261,000	14,936,000	-1,816,000	-8,643,000	-15,611,000	21,540,000	-6,678,000	-6,098,000	-18,597,000	12,519,000	-7,183,000	4,910,000	-17,151,000
prepaid expenses and other assets																								-1,453,000	1,289,000	401,000	-6,667,000	2,730,000	3,128,000	-7,623,000	-831,000	3,700,000	815,000	-79,000	-4,161,000	-824,000	1,577,000	-1,383,000	-603,000	7,964,000	-7,983,000	48,000	40,000	-475,000	61,000	939,000	-835,000	441,000	1,084,000	-103,000	-2,582,000	288,000	1,669,000	-714,000
due to employees																								-846,000	-29,078,000	24,297,000	-2,474,000	2,658,000	-10,305,000	11,656,000	-4,006,000	1,390,000	-4,062,000	8,611,000	-2,786,000	1,450,000	-5,823,000	12,420,000	-1,543,000	693,000	378,000	3,224,000	332,000	494,000	1,916,000	4,711,000	-1,796,000	700,000	-1,310,000	3,191,000	-675,000	-1,411,000	-785,000	5,767,000
taxes payable																								-3,898,000	-6,467,000	-16,045,000	19,636,000	-2,101,000	-3,743,000	3,848,000	72,938,000	-6,666,000	-2,927,000	7,135,000	2,880,000	3,231,000	-667,000	-3,173,000	17,771,000	-3,975,000	7,049,000	-11,873,000	11,833,000	3,237,000	5,502,000	-3,704,000	3,004,000	2,247,000	3,067,000	-5,244,000	6,856,000	1,166,000	-351,000	-2,173,000
excess tax benefit on stock-based compensation plans																																			-495,000	-419,000	-2,310,000	-2,040,000	-5,245,000	-736,000	-1,946,000	-436,000	-1,225,000	-390,000	-1,166,000	-995,000		-1,674,000	-1,721,000	-1,529,000		1,334,000	141,000	160,000
changes in operating assets and liabilities:
(increase)/decrease in operating assets:
increase/(decrease) in operating liabilities:
payments of withholding taxes related to net share settlements of restricted stockunits
acquisition of businesses, deferred consideration
employee housing loans issued																												-50,000	-106,000	-108,000	-30,000	-106,000	-142,000	-370,000	-645,000	-420,000				-1,074,000	-653,000	-266,000
proceeds from repayments of employee housing loans																												294,000	400,000	519,000	668,000	582,000	626,000	689,000	580,000	569,000	558,000	470,000	638,000	521,000	572,000	518,000	490,000	447,000	437,000	419,000	919,000	449,000
decrease/(increase) in time deposits
depreciation and amortization																														8,176,000	7,696,000	7,174,000	7,020,000	6,672,000	6,237,000	5,925,000	6,123,000	5,102,000	4,899,000	4,393,000	3,903,000	4,200,000	2,833,000	5,510,000	5,451,000	3,689,000	3,743,000	3,906,000	3,854,000	3,617,000	3,208,000	3,040,000	2,423,000	2,211,000
impairment charges and acquisition related adjustments
cash flows used in investing activities:
payment for construction of corporate facilities																																							-21,000	-1,159,000	-1,921,000	-1,591,000	-383,000	-1,259,000	-794,000	-1,488,000		-2,502,000	-198,000	-808,000	-285,000
restricted cash and time deposits
proceeds related to stock option exercises
effect of exchange rate changes on cash and cash equivalents																															1,337,000	4,464,000	2,894,000	2,928,000	-3,890,000	144,000	-998,000	1,358,000	-2,827,000	-2,486,000	2,215,000	-2,650,000	-5,884,000	-3,559,000	1,265,000	-2,787,000		714,000	-341,000	-1,133,000		1,099,000	-1,149,000	1,095,000
net increase/(decrease) in cash and cash equivalents																																			31,398,000	49,903,000	35,847,000	45,428,000
cash and cash equivalents, beginning of period																															0	0	0	362,025,000	0	0	0	199,449,000	0	0	0	220,534,000	0	0	0	169,207,000		0	0	118,112,000		0	0	88,796,000
cash and cash equivalents, end of period																															70,092,000	68,992,000	45,082,000	398,419,000	31,398,000	49,903,000	35,847,000	244,877,000	-14,994,000	38,726,000	-16,646,000	192,363,000	29,288,000	16,171,000	1,009,000	174,066,000		15,504,000	4,669,000	102,806,000		955,000	-7,806,000	112,736,000
deferred income taxes																																2,152,000
increase in operating assets:
increase in operating liabilities:
increase in restricted cash and time deposits																																							3,000	8,000	4,000	-29,959,000
acquisition of business, deferred consideration																																				0	-1,797,000	-463,000	0	0	-27,473,000	-2,801,000
net increase in cash and cash equivalents																																68,992,000	45,082,000	36,394,000									29,288,000				46,228,000				12,227,000	955,000
decrease in restricted cash and time deposits																																	56,000	38,000									1,123,000	4,000
increase in other long-term assets																																		-313,000	-1,667,000	-545,000	-1,341,000	-774,000	280,000	-177,000	-130,000	-681,000	-980,000	-153,000			-193,000	-3,000	-198,000	-122,000
proceeds from government grants																																			0	0	0	135,000
(increase)/decrease in restricted cash and time deposits
deferred revenues																																				473,000	122,000	-55,000	-262,000	-148,000	-450,000	-9,000	553,000	-1,812,000	-520,000	265,000
decrease/(increase) in restricted cash and time deposits																																				10,000	-9,000	30,000,000
proceeds from foreign currency derivatives
payments for foreign currency derivatives																																				-50,000	50,000	-91,000
proceeds related to stock options exercises																																					9,470,000	3,108,000	3,068,000	3,652,000	10,100,000	3,855,000	3,763,000	1,395,000	3,274,000	2,139,000	1,517,000	2,430,000	2,843,000	2,510,000	2,456,000
net cash provided by/ (used in) investing activities																																						23,420,000
(increase)/ decrease in operating assets:
increase/ (decrease) in operating liabilities:
employee housing loans																																											-424,000	-517,000	-505,000	-294,000		-1,873,000	-2,338,000	-2,834,000
proceeds from borrowing under line of credit																																							20,000,000
net increase/ (decrease) in cash and cash equivalents																																							-14,994,000	38,726,000	-16,646,000	-28,171,000			1,009,000	4,859,000								23,940,000
supplemental disclosures of cash paid:
income taxes
bank interest
net cash provided by/ (used in) financing activities
impairment and acquisition related charges
non-cash stock charge																																																			0	0	0	640,000
net proceeds from issuance of common stock in initial public offering																																																			0	0	1,193,000	31,171,000
costs related to stock issue																																																			1,000	0
net cash provided by/ (used in) operating activities																																													16,839,000	16,188,000
decrease/(increase) in other long-term assets																																														-350,000
excess tax benefits on stock-based compensation plans																																																			-1,662,000
goodwill impairment loss
change in operating assets and liabilities
payments for construction of corporate facilities
issuance of employee housing loans
decrease/
proceeds related to line of credit
repayment related to line of credit
effect of exchange-rate changes on cash and cash equivalents
cash and cash equivalents, beginning of year-january 1
cash and cash equivalents, end of year
supplemental disclosures of cash flow information:
cash paid during the year for:
bad debt provision
deferred revenue																																																-752,000	-1,136,000	-1,923,000	2,620,000	-905,000	-857,000	-1,625,000
decrease/ (increase) in restricted cash
acquisitions of businesses, net of cash acquired																																																0
adjustments to reconcile net income to net cash (used in)/ provided by operating activities:
bad debt provision/																																																	642,000	161,000
stock-based compensation																																																	3,850,000	2,576,000	1,457,000	2,046,000	1,773,000	1,550,000
increase/ (decrease) in operating assets and liabilities:
accrued expenses																																																	-601,000	-12,094,000				-12,057,000
net cash (used in)/ provided by operating activities
decrease in restricted cash																																																	532,000	177,000
net (decrease)/ increase in cash and cash equivalents																																																	4,669,000	-15,306,000
change in operating assets and liabilities:
(increase)/decrease in:
purchase of treasury stock
proceeds from sale of treasury stock, net of costs
repurchase of series a-2 convertible redeemable preferred stock
proceeds from issue of series a-3 convertible preferred stock, net of costs
decrease/(increase) in restricted cash and other long-term assets																																																				-734,000	-83,000	177,000
bad debt (recovery) /expense
payment for construction of building in minsk																																																					-2,660,000	-572,000
(gain)/loss on asset disposals
non-cash write offs
increase in:
(increase)/decrease in restricted cash and other long-term assets
net cash (used in) investing activities
costs related to potential stock issue

We provide you with 20 years of cash flow statements for EPAM Systems stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EPAM Systems stock. Explore the full financial landscape of EPAM Systems stock with our expertly curated income statements.

The information provided in this report about EPAM Systems stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.